Exir Gostar Espadana Pharmaceutical Company was established in 2013 as a private joint-stock company and since 2017, the aim was meeting the country’s pharmaceutical needs at the highest quality level following international standards. The most important goal of Exir Gostar Espadana Company is to produce and supply drugs with acceptable quality that are competitive in the pharmaceutical market and also to increase the satisfaction of consumers and patients. At the same time, in parallel with the efforts to maintain the market share, by producing the products needed by the society, it can strengthen its presence in the domestic and foreign markets and achieve the company’s innovative goals by achieving appropriate profitability. Improving the quality of the products produced and having up-to-date knowledge of pharmacy to create a suitable and favorable environment for the continuation of life and long-term survival are other goals of this pharmaceutical company.